The 55c price is not fair value, at c7x EBITDA it reflects where RXP should trade. 55c barely factors a control premium, let alone the synergies CapGemini will be able to derive from integrating the business.
The 55c price is not fair value, at c7x EBITDA it reflects where...
Add to My Watchlist
What is My Watchlist?